We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Myhealthchecked Plc | LSE:MHC | London | Ordinary Share | GB00BN7K5L93 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | 10.00 | 9.50 | 10.00 | 206,629 | 08:00:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 22.31M | 1.52M | 0.0292 | 3.42 | 5.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/2/2024 16:33 | Spacedust You’re depressing me now. Lol It’s is what it is. Unless you bought at 9p! You’re stuck like most other shareholders. Even the Directors won’t buy | tia01 | |
29/2/2024 12:43 | Hbr is making huge profits...increasing divi Company on the path to unlimited amount of share buy backs spending 100s of milions for the past 3 yrs non stop and the share price crashes | spacedust | |
29/2/2024 11:53 | British Airways had a fantastic rns today. The share price is down though. | spacedust | |
29/2/2024 07:06 | Spacedust What’s clear is MhC are focused on maintaining cash. Unless a plan to push sales in higher priced products MHC may be forced to consider whether production cost v sales make them cost effective!. I only see the lower end ones selling daily and the intolerance one which was gaining traction isn’t online due to stock issues. The company via walbrook blames Boots end! Sorry but this all needs addressing. A great product with prospects but a proper plan needed such as NHS contracts to encourage people to use the tests instead of GPs and doctors. This would save NHS millions and free up many hours for appointments. Also private company testing needs to be explored along with insurance companies etc. Then we have Gyms etc but nothing pro active other than a single Boots deal. Sorry but sometimes a company needs to think of shareholders and not just salaries | tia01 | |
28/2/2024 22:22 | They need to raise the price to 19p then 29p ans you'll get FOMO in full force to get buyers in then over 60p plus to entice sellers like me | spacedust | |
28/2/2024 18:10 | I totally am shocked they ain’t replenished stock of intolerance tests that were beginning to sell so well. It’s truly shocking and an explanation required. How do you grow revenue when stock not replenished | tia01 | |
28/2/2024 17:28 | Spacedust Stop having a melt down. Hardly any shares traded. They need to lower the price to encourage buyers. Maybe Penny will buy a few! Wishful thinking | tia01 | |
28/2/2024 13:22 | Fantastic news = decline in sp More revenue = decline in sp More cash = decline in sp More products = define in sp Please no more great news. We need shtt news with huge debts | spacedust | |
28/2/2024 07:55 | This share is baffling More cash than market cap and it goes down! | tia01 | |
26/2/2024 17:35 | Dual Did you ask how sales were going on the tests. I think they will show traction and I genuinely see Boots setting up for products that the NHS will approve for patients to get on prescription using Boots chemist services. It’s clear that the NHS will save millions on GP appointments etc so cost saving to the NHS. Penny alerted to this in the investor Meeting. A couple of decent share sales today but I don’t think it will follow through tomorrow and think if it holds it’s a Positive | tia01 | |
26/2/2024 17:07 | justWaiTing fer 5o% uFF sale | andymunchkin | |
25/2/2024 15:31 | I was in Boots earlier and the boots own brand LFT Vit D and Iron test were on sale next to MHC ones at tha same price.. A very strange setup, more interesting, is that the Boots test may have been supplied by MHC. All LTF test were 3 for 2 as well. | dual | |
25/2/2024 08:18 | In the investor meeting Penny said we would be concentrating on partnerships etc with other companies. I believe one such company would be ABDX. This company has quite an extensive range of tests but it’s main selling one is a pregnancy test which is fitting given our history in this sector at the start of our journey. I have also noticed they are concentrating on revenue growth but clearly have cash issues and burning it at an alarming pace. Unlike MHC who have cash but need growth revenue from new products. These companies could actually find commercial and common grounds working together as ABDX products are on sale in supermarkets etc. Maybe time to work with others or given ABDX low valuation keep an eye for a potential merger!. Either way there’s something that suggests these two companies would really benefit from a collaboration | tia01 | |
24/2/2024 11:31 | Space dust If you piled into MHC at Christmas you’d be 50% up. Unfortunately we all piled in way higher. We are supposed to buy low and sell high. Some how we have all bought high but I won’t be selling low | tia01 | |
23/2/2024 15:23 | I'm piling in Vodafone with all four elbows bud | spacedust | |
23/2/2024 15:18 | The other positive is we’re above the 200DMA average and the longer we are the better. Come on Penny do yourself a favour and buy some to get the party started. I beginning to wonder if the board are still at the Christmas Party. | tia01 | |
23/2/2024 15:14 | 30 vitamin D tests sold in the last 24hrs. If only all the 20 tests sold 30 a day we’d be 50p a share lol. hxxps://www.boots.co Spacedust Invest some cash and show us the way | tia01 | |
23/2/2024 11:32 | Mucky mouse size trades pushing this up. We need pumping big time | spacedust | |
22/2/2024 17:05 | hxxps://www.marketsc So just checking and I believe the figure per share pre consolidation was around 1p just over and the was around 15p after consolidation per share. They initially increased to around 28p then the bad results for first came and knocked 2/3rds off the value. The crazy thing is Penny did warn of a slowdown prior to the rise. What’s even more crazy the second half figures were quite amazing for a small company. They ended the year with just under 8m in the bank and less than 7m market cap. No debt. So my question is PE of just 4.5 really grossly undervaluing the good work at MHC and should it truly be at the very least back in the high 20s before it crashed on the first half results of 2023. Does Penny have something up her sleeve to move the price higher! Many other shares with mega debt etc flying whilst we are creeping! | tia01 | |
21/2/2024 22:03 | If only some people would believe it’s possible we can be worth a buy rating. I topped up yesterday and will continue to believe we can continue progress. This company is a story of success in a time when others struggling. If companies like MHC are neglected by the stock markets and investors then what hope is there for the UKs small companies. This company has more cash that valuation and no debt. Receives interest on cash in the bank and over 20 products and valued at over 80% less than when it had no products. Well the time will come when news drops and the Heard may turn up. | tia01 | |
21/2/2024 20:30 | Money...take a hike pal | spacedust | |
21/2/2024 19:37 | Black horse Without being disrespectful but Money obviously moving to MHC which is why we are 50% up from December roughly. Given we are on MHC site I’m happy to discuss money inflowing to MHC. All be it I wish a bit bit quicker lol. The fact is it’s ticking up without any one noticing it so hopefully a good RNS will come and get MHC noticed. I do see resistance at 16-17p if we get there as this was the figure around the time we fell early 2023 when the poor figures landed. I do however feel whilst we have seen a slowdown in covid sales that it’s possible new products are gaining traction. I do think a explanation as to why some of the good likes like intolerance tests are out of stock for so long online but can only assume that potential buyers will still go to stores nearby or use MHCs site directly. I feel the next set of results will be a much better set than lasts years. More cash in the bank and I have a sneaky feeling we are probably going to drop news on a few new products in my opinion. Also need a plan to move more expensive ones otherwise you have to judge if production costs are worth it in the sales figures given they have shelf life expiring dates. Also is MHC a takeover target with cash situation and no debts. I just wonder why Directors not buying and wonder if they are excluded because they are privileged to News coming. All my own personal beliefs but hopefully something soon to take it up to the next level and back to 25p plus as Spacedust said | tia01 | |
21/2/2024 14:43 | Money moving to APH [LSE] , excellent growing health care company | blackhorse23 | |
21/2/2024 13:47 | Tia I take the point and agree. But almost 99% of companies who consolidated the price never ever recovered. Tly Sar Ppa Ecr Pyc Song bird estates Edl Grl The list is endless honestly | spacedust | |
21/2/2024 12:35 | Consolidation has nothing to do with it. The percentage owned is the the same. The bad first half results in 2023 are to blame but the markets were pre warned about Covid slowdown. The key to this rocketing is new product sales | tia01 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions